A Phase II Study of Fazarabine in Patients with Advanced Ovarian Cancer A Gynecologic Oncology Group Study

American Journal of Clinical Oncology ◽

10.1097/00000421-199504000-00012 ◽

1995 ◽

Vol 18 (2) ◽

pp. 156-157 ◽

Author(s):

Alberto Manetta ◽

John A. Blessing ◽

Katherine Y. Look

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e112 ◽

2019 ◽

Vol 30 (6) ◽

Author(s):

Jung-Yun Lee ◽

Jae Weon Kim ◽

Myong Cheol Lim ◽

Sunghoon Kim ◽

Hee Seung Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A PHASE II STUDY WITH ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER IN DEVELOPING COUNTRY: A SHANGHAI GYNECOLOGIC ONCOLOGY GROUP AICE TRIAL

10.26226/morressier.57baab48d462b80290b4bff4 ◽

2016 ◽

Author(s):

Rong Jiang

Keyword(s):

Ovarian Cancer ◽

Developing Country ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Line Chemotherapy

Download Full-text

Faculty of 1000 evaluation for Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812).

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717962364.793467463 ◽

2012 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Interval Debulking Surgery

Download Full-text

Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1993.1084 ◽

1993 ◽

Vol 49 (1) ◽

pp. 48-50 ◽

Author(s):

Gregory P. Sutton ◽

John A. Blessing ◽

Philip J. DiSaia ◽

William P. McGuire

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.043 ◽

2006 ◽

Vol 103 (2) ◽

pp. 523-526 ◽

Author(s):

Paula M. Fracasso ◽

John A. Blessing ◽

Kelly L. Molpus ◽

Lisa M. Adler ◽

Joel I. Sorosky ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Second Line ◽

Oncology Group ◽

Oncology Group Study ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Download Full-text

Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.10.001 ◽

2013 ◽

Vol 128 (1) ◽

pp. 22-27 ◽

Author(s):

Hiroshi Tsubamoto ◽

Yoshio Itani ◽

Kimihiko Ito ◽

Riichiro Kanazawa ◽

Shinji Toyoda ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Interval Debulking Surgery

Download Full-text

Phase II study of esorubicin (4?-deozydoxorubicin) in advanced epithelial carcinoma of the ovary: A Gynecologic Oncology Group study

Investigational New Drugs ◽

10.1007/bf00173763 ◽

1989 ◽

Vol 7 (4) ◽

Author(s):

WilliamP. McGuire ◽

JohnA. Blessing ◽

MichaelL. Berman

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Carcinoma Of The Ovary

Download Full-text

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

Gynecologic Oncology ◽

10.1006/gyno.1997.4887 ◽

1998 ◽

Vol 68 (1) ◽

pp. 45-46 ◽

Author(s):

Alberto Manetta ◽

John A. Blessing ◽

Jean A. Hurteau

Keyword(s):

Ovarian Cancer ◽

Cyclosporin A ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Platinum Resistant

Download Full-text

2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.07.079 ◽

2014 ◽

Vol 134 (2) ◽

pp. 438-439 ◽

Author(s):

R.J. Osborne ◽

V.L. Filiaci ◽

R.S. Mannel ◽

S.A. Davidson ◽

J.S. Hoffman ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Low Risk ◽

Gynecologic Oncology Group ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Initial Management ◽

Oncology Group Study

Download Full-text

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.5755 ◽

2000 ◽

Vol 77 (1) ◽

pp. 112-115 ◽

Author(s):

Maurie Markman ◽

John A. Blessing ◽

Ronald D. Alvarez ◽

Parviz Hanjani ◽

Steven Waggoner ◽

...

Keyword(s):

Ovarian Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Platinum Sensitive

Download Full-text